Vasodilator and constrictor actions of platelet-activating factor in the isolated microperfused afferent arteriole of the rabbit kidney. Role of endothelium-derived relaxing factor/nitric oxide and cyclooxygenase products
- PMID: 8473488
- PMCID: PMC288109
- DOI: 10.1172/JCI116339
Vasodilator and constrictor actions of platelet-activating factor in the isolated microperfused afferent arteriole of the rabbit kidney. Role of endothelium-derived relaxing factor/nitric oxide and cyclooxygenase products
Abstract
It has been suggested that platelet-activating factor (PAF) plays a prominent role in the control of glomerular hemodynamics in various physiological and pathological conditions. We examined the direct effect of PAF on rabbit glomerular afferent arterioles (Af-Arts) microperfused in vitro and tested whether endothelium-derived relaxing factor/nitric oxide (EDNO) and cyclooxygenase products are involved in its actions. In nanomolar concentrations PAF caused dose-dependent constriction of Af-Arts, with the maximum constriction being 34 +/- 10% at 4 x 10(-8) M (n = 9, P < 0.001). The constriction was blunted by cyclooxygenase inhibition (11 +/- 6%, n = 7, P < 0.05) but augmented by EDNO inhibition (76 +/- 14%, n = 8, P < 0.005). To study a possible vasodilator effect of PAF, Af-Arts were preconstricted with norepinephrine and increasing concentrations of PAF added to the lumen. At picomolar concentrations (lower than those that caused constriction), PAF produced dose-dependent vasodilation that was unaffected by cyclooxygenase inhibition but was abolished by EDNO synthesis inhibition. Both PAF-induced constriction and dilation of Af-Arts were blocked by a PAF receptor antagonist. This study demonstrates that PAF has a receptor-mediated biphasic effect on rabbit Af-Arts, dilating them at low concentrations while constricting them at higher concentrations. Our results suggest that PAF's vasodilator action may be due to production of EDNO, while its constrictor action is mediated at least in part through cyclooxygenase products.
Similar articles
-
Platelet-activating factor dilates efferent arterioles through glomerulus-derived nitric oxide.J Am Soc Nephrol. 1996 Jan;7(1):90-6. doi: 10.1681/ASN.V7190. J Am Soc Nephrol. 1996. PMID: 8808114
-
Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole.J Clin Invest. 1993 May;91(5):2012-9. doi: 10.1172/JCI116423. J Clin Invest. 1993. PMID: 8486771 Free PMC article.
-
Mechanism involved in bradykinin-induced efferent arteriole dilation.Kidney Int. 2002 Aug;62(2):544-9. doi: 10.1046/j.1523-1755.2002.00482.x. Kidney Int. 2002. PMID: 12110016
-
Platelet-activating factor in human endometrium.J Steroid Biochem Mol Biol. 1994 Jun;49(4-6):359-63. doi: 10.1016/0960-0760(94)90280-1. J Steroid Biochem Mol Biol. 1994. PMID: 8043501 Review.
-
Platelet-activating factor (PAF): an introduction.Lipids. 1991 Dec;26(12):965-6. doi: 10.1007/BF02536485. Lipids. 1991. PMID: 1819750 Review. No abstract available.
Cited by
-
Nuclear localization of platelet-activating factor receptor controls retinal neovascularization.Cell Discov. 2016 Jul 12;2:16017. doi: 10.1038/celldisc.2016.17. eCollection 2016. Cell Discov. 2016. PMID: 27462464 Free PMC article.
-
Cyclic guanosine monophosphate is the mediator of platelet-activating factor inhibition on transport by the mouse kidney thick ascending limb.J Clin Invest. 1994 Sep;94(3):1156-62. doi: 10.1172/JCI117431. J Clin Invest. 1994. PMID: 7521885 Free PMC article.
-
The pathophysiological effects of Russell's viper (Daboia siamensis) venom and its fractions in the isolated perfused rabbit kidney model: A potential role for platelet activating factor.Toxicon X. 2020 Jun 7;7:100046. doi: 10.1016/j.toxcx.2020.100046. eCollection 2020 Sep. Toxicon X. 2020. PMID: 32875291 Free PMC article.
-
Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs.Br J Pharmacol. 1996 Jun;118(4):941-50. doi: 10.1111/j.1476-5381.1996.tb15490.x. Br J Pharmacol. 1996. PMID: 8799566 Free PMC article.